NCT03672812View on ClinicalTrials.gov

The Use of Liraglutide in Brain Death

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

February 10, 2022

Conditions
Brain Death
Interventions
DRUG

Liraglutide

liraglutide 3mg 6/6 hours

Trial Locations (1)

89010380

Hospital Santa Isabel, Blumenau

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT03672812 - The Use of Liraglutide in Brain Death | Biotech Hunter | Biotech Hunter